Molecular diagnosis methods in familial hypercholesterolemia
Familial hypercholesterolemia (FH) is considered the genetic cause of coronary heart disease and ischemic stroke. FH is mainly an autosomal codominant pattern-based disorder and is primarily determined by point mutations within the low-density lipoprotein receptor, apolipoprotein B, and proprotein c...
Main Authors: | Valeriu Moldovan, Claudia Banescu, Minodora Dobreanu |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2020-02-01
|
Series: | Anatolian Journal of Cardiology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-95038 |
Similar Items
-
A Global Review on the Utility of Genetic Testing for Familial Hypercholesterolemia
by: Rachele M. Hendricks-Sturrup, et al.
Published: (2020-04-01) -
2022 Consensus statement on the management of familial hypercholesterolemia in Korea
by: Chan Joo Lee, et al.
Published: (2022-09-01) -
Familial hypercholesterolemia within cardiology practice – single-center experience during 2-year period
by: Edin Begic, et al.
Published: (2022-01-01) -
Long-term follow-up in patients with homozygous familial hypercholesterolemia; 13-year experience of a university hospital lipid clinic
by: Meral Kayıkçıoğlu, et al.
Published: (2014-10-01) -
ASPECTS OF DETECTING PATIENTS WITH FAMILY HYPERCHOLESTEROLEMIA
by: P M Kurbanismailova, et al.
Published: (2017-09-01)